The consumption of plant food supplements (PFS) has been growing globally, with an increase of misleading labeling and fraudulent practices also being reported. Recently, the use of molecular biology techniques has been proposed to detect botanical adulterations, one of the possible frauds in PFS. However, difficulties in recovering DNA from some PFS samples have been described. Aiming at using DNA-based methods for the unequivocal identification of plant species in PFS, adequate DNA isolation is required. However, PFS often contain pharmaceutical excipients known to have adsorbent properties that might interfere with DNA extraction. Thus, the aim of this work was to assess the effect of different excipients (talc, silica, iron oxide and titanium dioxide) on the recovery/amplification of DNA. For that purpose, known amounts of template maize DNA were spiked either to PFS or to model mixtures of excipients and quantified by real-time PCR. The tested excipients evidenced clear adsorption phenomena that justify the hampering effect on DNA extraction from PFS. The use of either 10% talc or 0.5% dyes completely adsorbed DNA, resulting in negative PCR amplifications. For the first time, pharmaceutical excipients were shown to affect DNA extraction explaining the inability of recovering DNA from some PFS samples in previous studies.
Introduction
During the last years, medicinal plants and products thereof have become increasingly available in the European Union (EU) market as ingredients in formulations sold as plant food supplements (PFS). This type of products has been growing in popularity, with its increased use being associated with a variety of factors such as the perception that plant products are safe and that "natural" is healthy. The mistrust in conventional medicine and a rising tendency for self-medication are also associated factors [1] . Additionally, trade globalization has brought to Europe a wide range of plants traditionally used in other continents, which are now offered in several popular PFS marketed in European countries [1] . For these reasons, the market for food supplements has been growing during the last years, with a consequent demand for plant material. This can result in a higher number of frauds and/or in increased possibility of unintentional swap of plants due to misidentification of wild collected specimens. Among possible adulterations of PFS, the intentional addition of plant fillers to increase product bulk and the substitution of high priced medicinal plants by other closely related/similar species should be considered [2, 3] . In both cases, namely adulterations or unintentional swap of plants, the PFS integrity might be compromised by the introduction of unknown phytochemicals arising from the unlabeled plant(s), which can directly affect the PFS efficacy [4] . Furthermore, the safety of these products is also jeopardized since cases of possible health risks resulting from undeclared plants in PFS have already been reported [5, 6] .
Therefore, to protect consumers, analytical methodologies that allow the identification of plant species, both in raw botanical materials and in the finished products/commercialized PFS, are required. So far, different methodologies have been proposed for the identification of plant species in PFS, including traditional methods such as morphologic evaluation (macro or microscopic observations) and chemical profiling [7e9] . Considering that these methods are not appropriated for PFS since they generally contain processed/powdered botanical mixtures [10] recent works have suggested the use of DNA molecules as diagnostic markers. As main advantages, these molecules are present in most cells and they are not affected by physiological plant conditions, unlike most phytochemical compounds [3, 11, 12] .
DNA-based techniques are considered highly sensitive and specific tools, allowing the successful identification of plant species, even in complex and very processed samples [13e16] . However, up to date, most of DNA methodologies reporting the identification of medicinal plant species essentially concern botanical raw materials and traditional herbal medicines [17e19] with few works being developed for the authentication of PFS. Newmaster et al. [3] used DNA barcoding for the authentication of 44 herbal products (41 capsules, 1 tablet and 2 powders) sold in North-America and 50 leaf samples from different species. The authors were able to recover barcodes from DNA extracts of all leaf samples, whereas for herbal products the success rate was 91% (40/44 products). Wallace et al. [12] used DNA sequence information through standardized DNA barcoding aiming at the authentication of 95 natural health products, including 70 from plant origin (tea, liquids, root pieces, root slices, capsules, tablets and caplets). Although the authors used multiple markers and primer sets, they were unable to recover DNA barcodes from 25% of the plant products, from which two were plant roots, while fourteen were capsules, tablets or caplets. Thus, DNA amplification was not accomplished for a much higher number of pharmaceutical formulations (14 in a total of 33 capsules, tablets and caplets), when compared to samples of botanical materials (2 in a total of 35 samples of teas and roots). This difference of results can possibly be related to the fact that formulations of PFS frequently contain pharmaceutical excipients such as diluents, fillers, binders, glidants, lubricants, pigments and stabilizers [20] . In particular, some excipients used in the manufacturing of PFS, such as micronized talc (hydrated magnesium silicate) and silica (silicon dioxide), are known to have adsorbent properties. As a result, a hamper effect on the DNA extraction from PFS samples might occur, compromising the subsequent amplification. To the best of our knowledge, no studies have been carried out regarding the evaluation of possible interferences of pharmaceutical excipients on DNA extraction yields. Thus, the aim of this work was to ascertain the effect of different excipients (talc, silica, iron oxide and titanium dioxide) in the recovery/amplification of known amounts of maize DNA added either to PFS samples or to different mixtures of pharmaceutical excipients.
Materials and methods

Samples of PFS
PFS were acquired at local pharmacies or gently provided by some companies (DietMed, Portugal and Distrifa, Portugal). To evaluate the influence of pharmaceutical excipients commonly used in capsules and tablets, four PFS were carefully chosen in order to contain: talc and/or silica, titanium dioxide and/or iron oxide. One of the samples was also specifically chosen without containing any of the referred excipients for comparative purposes. None of the five PFS had maize starch included in their formulations. The complete description of each PFS composition is presented in Table 1 . PFS were independently grinded and homogenized in mortars previously treated with DNA decontamination solution (DNA-ExitusPlus ™ , AppliChem, Darmstadt, Germany). To assess the effect of the matrix during DNA extraction, rice powder was also used.
Mixtures of different pharmaceutical excipients
Several mixtures containing different quantities of the pharmaceutical excipients under analysis, namely silica, talc, titanium dioxide and iron oxide, were prepared using microcrystalline cellulose as tablet/capsule diluent. The quantities of the excipients under study were chosen according to their specific functions in tablets/capsules formulations [20] . The complete description of the assayed mixtures of excipients is included in Table 2 . Briefly, a total of eleven formulations were prepared using talc and/or silica as glidants/lubricant agents and titanium dioxide and/or iron oxide as dyes. Since cellulose is not described as having DNA adsorbent properties, it was used as a bulk excipient (100% microcrystalline cellulose, without any of the tested excipients). Mixtures containing 1% and 10% of silica (M1, M2), 1% and 10% of talc (M3, M4), 1% of silica and 1% talc (M5), 0.5% and 1% of titanium dioxide (M6, M7), 0.5% and 1% of iron oxide (M8, M9) and 1% of titanium dioxide plus 1% of iron oxide (M10) were prepared in cellulose. The mixtures were independently homogenized in mortars previously treated with DNA decontamination solution (DNA-ExitusPlus™, AppliChem, Darmstadt, Germany).
DNA extraction
Portions of 100 mg of each PFS (Table 1) or each pharmaceutical excipient mixture (Table 2) , previously homogenized, were weighted in sterile reaction tubes. DNA was extracted using the commercial DNA extraction kit Nucleospin Plant II (MachereyeNagel, Düren, Germany), according to the manufacturer's instructions with minor alterations. Before performing DNA extraction protocol, 100 mL of maize DNA (50 ng) were added to each PFS, mixture or rice and incubated for 30 min at 37 C with soft stirring (300 rpm). After the incubation step, 300 mL of PL2 lysis solution pre-heated at 65 C were added to each sample. After an incubation period of 1 h at 65 C with continuous stirring (1000 rpm), 75 mL of buffer PL3 were mixed in each tube and incubated for 5 min on ice to completely precipitate the SDS (sodium dodecyl sulphate). The samples were centrifuged at 11,000g, at room temperature for 2 min, and filtered through the NucleoSpin filter. Then, 450 mL of buffer PC (binding solution) were added to each lysate, mixed by gentle inversion and the volume eluted through a spin column (NucleoSpin Plant II Column) by centrifugation (1 min, 11,000 g at room temperature). The spin column was washed three times with 400 mL of PW1 solution, 700 mL and 200 mL of PW2 solution, followed by 1 min of centrifugation after the two first washes and a 2 min final centrifugation (11,000 g at room temperature). The elution step was performed twice with 50 mL of PE solution at 65 C, followed by 5 min of incubation at 65 C and centrifugation (1 min, 11,000g), in order to maximize DNA yield. DNA extracts were immediately kept at À20 C until further analysis. The extractions were performed at least in duplicate for each sample and mixture.
Yield and purity of extracts were assessed by 1% agarose gel electrophoresis and by UV spectrophotometric DNA quantification on a Synergy HT multi-mode microplate reader (BioTek Instruments, Inc., Vermont, USA), using a Take3 micro-volume plate accessory. DNA content was determined using the nucleic acid quantification protocol with sample type defined for double-strand DNA in the Gen5 data analysis software version 2.01 (BioTek Instruments, Inc., Vermont, USA).
Real-time PCR
Alcohol dehydrogenase gene (adh) was chosen as a marker for maize quantification since it is considered a taxon-specific (endogenous) gene for Zea mays L. For this purpose, specific primers (adh1-F, CCA GCC TCA TGG CCA AAG; adh1-R, CCT TCT TGG CGG CTT ATC TG) and probe (adh1-P, FAM-CTT AGG GGC AGA CTC CCG TGT TCC CT-BHQ1) targeting the adh1 gene were selected from the literature [21] .
Amplifications by real-time PCR were performed in 20 mL of total reaction volume containing 2 mL of DNA extract, 1 Â of Sso-
Fast
™ Probes Supermix, 200 nM of each primer adh1-F/adh1-R and 100 nM of adh1-P probe. The assays were carried out in a fluorometric thermal cycler CFX96 Real-time PCR Detection System (BioRad, Hercules, CA, USA) using the following conditions: 95 C for 5 min; 50 cycles at 95 C for 15 s and 60 C for 45 s, with collection of fluorescence signal at the end of each cycle. Data were processed using the software Bio-Rad CFX Manager 3.1 (BioRad, Hercules, CA, USA). Each extract was amplified in quadruplicate in two independent assays.
Results and discussion
Following a preliminary study of our working group, in which several PFS were tentatively submitted to DNA extraction using different protocols (including in-house optimized extraction methods and different commercial kits) that frequently resulted in negative PCR amplification targeting a eukaryotic gene, we decide to investigate the reasons behind this finding. Although amplifiable DNA was extracted from several PFS, for others, negative results were always obtained, irrespectively of the extraction method used (unpublished data). In most of these PFS, the formulation label described the inclusion of fragmented aerial plant parts, so it was expectable the presence of extractable plant DNA. The PFS under analysis were capsules and tablets that generally contain additional materials, other than plants/plant extracts in their composition, such as binders, diluents, glidants, lubricants, colorants and stabilizers. When carefully analyzing the ingredient list of the formulations for which the extraction of amplifiable DNA was not accomplished, we realized that most PFS had in common the inclusion of some excipients, namely talc and silica. It is known that DNA can be adsorbed onto silica surfaces, being this phenomena the basis for DNA purification via solid-phase extraction used in several commercial DNA extraction kits, and also by using silica nanoparticles [22e24]. The adsorption of DNA onto the surface of silica nanoparticles used in DNA extraction from biological samples is mainly explained by weak electrostatic repulsion forces, dehydration and hydrogen bonds [25, 26] . Moreover, it has also been proposed that adsorption of nucleic acids onto mineral surfaces can occur due to ionic interactions between the negatively charged phosphate groups of DNA and the positively charged surface groups [27] . Thus, taking into account the adsorbent properties of talc [28] , it is possible that DNA could also be adsorbed to this excipient. Moreover, based on the excipients listed from non-amplifiable PFS extracts, other compounds, such as iron oxide and titanium dioxide, used as colorants (dyes) in some formulations, could also have a hampering effect on DNA extraction from PFS. According to the available literature, iron oxide magnetic nanoparticles have already been used for DNA adsorption to isolate it from mammalian cells [29] and from herring sperm [30] . The adsorption of fluorescent labeled DNA oligonucleotides on titanium dioxide nanoparticles has been shown to take place mainly via the backbone phosphate [31] .
Therefore, in the present work we intended to evaluate if the referred pharmaceutical excipients (silica, talc, iron oxide and titanium dioxide) could be retaining DNA from PFS. For this purpose, five selected PFS samples and eleven model excipient mixtures were spiked with a known amount of maize DNA to work as an internal standard. The samples and mixtures were then submitted to DNA extraction and amplified by real-time PCR targeting a maize DNA fragment for quantification. Hypericum perforatum (extract of the aerial parts containing at least 900 mg of hypericin); gelatin; dicalcium phosphate; silica (silicon dioxide); vegetable magnesium stearate. PFS5
Garcinia cambogia 14.8%; Hypericum perforatum 11.1%; Glycine max: lecithin (14% phosphatidylinositol and 23% phosphatidylcholine); L-carnitine 9.3%; microcrystalline cellulose 7.4%; Pyrus malus (pectin) 5.6%; lactose; anti-agglomerating: tricalcium phosphate, talc (magnesium silicate); chromium, trichloride 0.01% 
PFS samples spiked with maize DNA extract
The five PFS under study included one sample (PFS1) that gave positive results for eukaryotic DNA amplification (using the method described by Costa et al. [32] ) and did not refer any of the pharmaceutical excipients under evaluation, and four PFS (PFS2-PFS5) that gave unsuccessful DNA amplification (Table 1) . To assess possible matrix effects, powdered rice was used as a non-interfering plant food matrix. Table 3 presents the results of the recovery assays of maize DNA in water (control without matrix), rice and PFS samples determined by quantitative real-time PCR. As can be observed, similar results were obtained for the control and the powdered rice (442.9 pg and 416.6 pg maize DNA, respectively). Taking the water control as reference, a high recovery of maize DNA (94%) was obtained from the rice matrix, indicating a negligible effect of plant material on DNA recovery. However, a much lower maize DNA amount (184.2 pg) was obtained from the PFS1 sample, without any of the excipients under evaluation, thus suggesting the existence of a matrix effect on DNA amplification that causes some inhibition noticed in amplification curve profile. When compared to the control, more than 40% of maize DNA was still recovered from the PFS1. Regarding the other PFS, no DNA was recovered from the spiked samples containing either talc (PFS2, PFS5) and/or silica (PFS2, PFS4) in their composition, showing a complete retaining effect on maize DNA extraction (Fig. 1A) . In the case of PFS3, containing titanium dioxide and iron oxide, only minute amounts of maize DNA (15.7 pg) were recovered. In this sample, titanium dioxide and iron oxide are most likely to be present at very low amounts since both compounds are generally used as coloring agents in pharmaceutical formulations ( 1%). Possibly for this reason, the hampering effect on DNA extraction was not as strong as in the PFS containing either talc and/or silica, which are used at higher amounts (as lubricants, gliders, binders or diluents) [20] .
Mixtures of pharmaceutical excipients spiked with maize DNA extract
Mixtures containing known amounts of the pharmaceutical excipients hypothesized to be responsible for adsorption phenomena were prepared using cellulose as diluent (Table 2) . Identically to PFS samples, recovery assays were performed by adding known amounts of maize DNA (50 ng) to the model mixtures.
Since talc is widely used in oral solid formulations as lubricant (up to 10%) or as diluent (up to 30%) [20] , initially, mixtures were prepared with 10%e30% of talc in cellulose. Additionally, previous mixtures containing 10% of talc added with different percentages of the other excipients, namely 1% and 10% silica; 0.5% and 1% coloring agents (titanium dioxide and iron oxide), were also prepared. In all these assayed mixtures, no DNA was recovered since no amplifications were obtained by real-time PCR targeting maize DNA, evidencing a total adsorption of the spiked DNA to the pharmaceutical excipients used (data not shown). Thus, new and different mixtures were prepared using lower amounts of each excipient under study. Table 2 shows the composition of each mixture and the respective maize DNA recovery results. As can be observed, a low DNA amount was recovered from the 100% cellulose material (blank) compared to the control (DNA in water), pointing to a possible interference of cellulose on DNA extraction (Fig. 1B) . Comparatively to the blank material, all tested excipients showed the capacity to adsorb DNA, although with different degrees (Fig. 1B and  C) . Talc seems to exert a stronger hampering effect on DNA extraction than silica. The mixture containing 1% of talc (M3) showed minute amounts of recovered maize DNA (7.1%), while the 10% (M4) completely adsorbed it. The 1% silica (M1) enabled a similar amount of recovered DNA as the blank (M0), suggesting that at this level none or negligible adsorption effect occurred. When silica was increased to 10% (M2), there was a considerable DNA retention (2.5% of recovery). Considering the mixture with both excipients at 1% (M5), the amount of recovered DNA reached an intermediate value (16.0%) between M1 and M3 with 1% silica or 1% talc, respectively (Table 2 ). In this case, it was expected a higher retention effect than using only 1% of talc, which suggest that both excipients may interact and decrease the DNA adsorption.
Regarding the mixtures containing different amounts of the dyes titanium dioxide and iron oxide (M6-M10), no amplification was obtained, showing a complete DNA retention in all the cases (Table 2) . These results are in good agreement with previous data that reported a very strong interaction between DNA and particles of cobalt ferrite (a compound composed of iron oxide) due to the high affinity of phosphate groups to iron oxides [22] .
Generally, the results from model excipient mixtures (Table 2 ) support the findings obtained in the analyzed PFS (Table 3) , regarding the presence or absence of the tested excipients. The presence of bulk or diluent agents such as cellulose (M0) or starch (PFS1) prompts high and close DNA adsorption phenomena. The absence of DNA amplification in the PFS2, PFS4 and PFS5 might be explained by the use of talc and/or silica at levels !10%, while minute amount of recovered DNA in PFS3 might result from the presence of titanium dioxide and iron oxide at lower proportions than 0.5%. It is also important to highlight that the presence of other non-tested components/excipients in the PFS formulations might contribute for synergic or antagonist interactions.
In conclusion, the results evidenced a clear adsorption phenomena with all the tested excipients (silica, talc, iron oxide and titanium oxide) that could justify the hampering effect on DNA extraction from PFS. Thus, when evaluating the results obtained for DNA analyses in PFS, researchers must consider the formulations and excipients described on the products label, as those can affect the outcome of analyses. Since most PFS are sold as capsules and tablets, which frequently include the tested pharmaceutical excipients, further research is required in order to identify a strategy to release plant DNA from such formulations for forthcoming authenticity purposes. Table 3 Real-time PCR quantification of maize DNA (used as internal standard) spiked into different matrixes (water, rice and PFS) based on 2 independent extractions with n ¼ 8 replicates. 
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